A

Amerisourcebergen Corp
LSE:0HF3

Watchlist Manager
Amerisourcebergen Corp
LSE:0HF3
Watchlist
Price: 237.12 USD -0.01% Market Closed
Market Cap: 49.1B USD
Have any thoughts about
Amerisourcebergen Corp?
Write Note

Amerisourcebergen Corp
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amerisourcebergen Corp
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
A
Amerisourcebergen Corp
LSE:0HF3
Long-Term Debt
$3.8B
CAGR 3-Years
-16%
CAGR 5-Years
-3%
CAGR 10-Years
7%
Cardinal Health Inc
NYSE:CAH
Long-Term Debt
$4.2B
CAGR 3-Years
-8%
CAGR 5-Years
-11%
CAGR 10-Years
3%
Henry Schein Inc
NASDAQ:HSIC
Long-Term Debt
$1.9B
CAGR 3-Years
39%
CAGR 5-Years
17%
CAGR 10-Years
12%
Patterson Companies Inc
NASDAQ:PDCO
Long-Term Debt
$325.4m
CAGR 3-Years
-13%
CAGR 5-Years
-13%
CAGR 10-Years
-8%
Mckesson Corp
NYSE:MCK
Long-Term Debt
$5.7B
CAGR 3-Years
-1%
CAGR 5-Years
-5%
CAGR 10-Years
-5%
Cencora Inc
NYSE:COR
Long-Term Debt
$3.8B
CAGR 3-Years
-16%
CAGR 5-Years
-3%
CAGR 10-Years
7%
No Stocks Found

Amerisourcebergen Corp
Glance View

Economic Moat
None
Market Cap
46.2B USD
Industry
Health Care

AmerisourceBergen Corp., a titan in the realm of pharmaceutical services, orchestrates the flow of medications across a vast and intricate network. Rooted in Chesterbrook, Pennsylvania, the company has cemented its place as a critical link in the healthcare supply chain. Serving as a bridge between pharmaceutical manufacturers and a wide array of healthcare providers like hospitals, clinics, and pharmacies, AmerisourceBergen leverages its expansive distribution infrastructure to ensure that medications and health products reach their destinations efficiently and reliably. The company's operations are bolstered by its strategic partnerships and collaboration with a plethora of healthcare entities, enabling it to integrate seamlessly into the delivery systems that support patient care. At its core, AmerisourceBergen turns the complexity of healthcare logistics into a streamlined process, generating revenue primarily through the distribution of pharmaceuticals. It purchases medications from manufacturers, sells them at a markup to healthcare providers, and in doing so, balances a robust supply chain fueled by efficiency and scale. But the story doesn't end at distribution; the company has expanded its reach through value-added services such as consulting, data analytics, and patient support services that further solidify its role in the healthcare ecosystem. Whether navigating regulatory environments or advising on patient care strategies, AmerisourceBergen positions itself as not just a distributor, but a partner in health. Through this dual approach of distribution and strategic services, the company ensures it remains vital to both manufacturers and healthcare providers, creating a sustainable business model that capitalizes on both volume and innovation.

0HF3 Intrinsic Value
434.05 USD
Undervaluation 45%
Intrinsic Value
Price
A

See Also

What is Amerisourcebergen Corp's Long-Term Debt?
Long-Term Debt
3.8B USD

Based on the financial report for Sep 30, 2024, Amerisourcebergen Corp's Long-Term Debt amounts to 3.8B USD.

What is Amerisourcebergen Corp's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
7%

Over the last year, the Long-Term Debt growth was -8%. The average annual Long-Term Debt growth rates for Amerisourcebergen Corp have been -16% over the past three years , -3% over the past five years , and 7% over the past ten years .

Back to Top